Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tan, AC"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł:
Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
Autorzy:
Klauck PJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Bagby SM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Capasso A; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Bradshaw-Pierce EL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; Takeda California, San Diego, CA, USA.
Selby HM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Spreafico A; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Tentler JJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Tan AC; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Kim J; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Arcaroli JJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Purkey A; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Messersmith WA; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Kuida K; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Eckhardt SG; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Pitts TM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. .; University of Colorado Cancer Center, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Feb 05; Vol. 18 (1), pp. 136. Date of Electronic Publication: 2018 Feb 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Xenograft Model Antitumor Assays*
Azepines/*pharmacology
Cell Cycle Proteins/*antagonists & inhibitors
Colorectal Neoplasms/*drug therapy
Protein Serine-Threonine Kinases/*antagonists & inhibitors
Proto-Oncogene Proteins/*antagonists & inhibitors
4-Aminobenzoic Acid/pharmacology ; Animals ; Antineoplastic Agents/pharmacology ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Colorectal Neoplasms/pathology ; Female ; G2 Phase Cell Cycle Checkpoints/drug effects ; HCT116 Cells ; HT29 Cells ; Humans ; Mice, Nude ; Protein Serine-Threonine Kinases/metabolism ; Proto-Oncogene Proteins/metabolism ; Tumor Burden/drug effects ; Polo-Like Kinase 1
Czasopismo naukowe
Tytuł:
Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer.
Autorzy:
Pitts TM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Newton TP; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Bradshaw-Pierce EL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Addison R; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Arcaroli JJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Klauck PJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Bagby SM; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Hyatt SL; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Purkey A; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America.
Tentler JJ; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Tan AC; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Messersmith WA; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Eckhardt SG; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Leong S; Division of Medical Oncology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States of America; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Nov 17; Vol. 9 (11), pp. e113037. Date of Electronic Publication: 2014 Nov 17 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Drug Synergism*
Phosphoinositide-3 Kinase Inhibitors*
Cell Proliferation/*drug effects
Colorectal Neoplasms/*drug therapy
Mitogen-Activated Protein Kinases/*antagonists & inhibitors
Protein Kinase Inhibitors/*pharmacology
TOR Serine-Threonine Kinases/*antagonists & inhibitors
Animals ; Antineoplastic Combined Chemotherapy Protocols ; Benzamides/pharmacology ; Cell Line, Tumor ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Diphenylamine/analogs & derivatives ; Diphenylamine/pharmacology ; Female ; Humans ; Immunoblotting ; Mice ; Mice, Nude ; Mitogen-Activated Protein Kinases/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction/drug effects ; TOR Serine-Threonine Kinases/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model.
Autorzy:
Arcaroli JJ; Department of Medicine, University of Colorado Cancer Center, University of Colorado Denver, Aurora, CO, USA.
Quackenbush KS
Purkey A
Powell RW
Pitts TM
Bagby S
Tan AC
Cross B
McPhillips K
Song EK
Tai WM
Winn RA
Bikkavilli K
Vanscoyk M
Eckhardt SG
Messersmith WA
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2013 Aug 06; Vol. 109 (3), pp. 667-75. Date of Electronic Publication: 2013 Jul 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Amyloid Precursor Protein Secretases/*antagonists & inhibitors
Colorectal Neoplasms/*drug therapy
Colorectal Neoplasms/*metabolism
Receptors, Notch/*metabolism
Tetrahydronaphthalenes/*pharmacology
Valine/*analogs & derivatives
Wnt Signaling Pathway/*drug effects
Adenocarcinoma/drug therapy ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adult ; Aged ; Animals ; Cell Growth Processes/drug effects ; Colorectal Neoplasms/pathology ; Enzyme Inhibitors/pharmacology ; Female ; Gene Knockdown Techniques ; HCT116 Cells ; Humans ; Mice ; Mice, Nude ; Middle Aged ; Random Allocation ; Valine/pharmacology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Autorzy:
Tijhuis MJ; Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Boerboom AM
Visker MH
Op den Camp L
Nagengast FM
Tan AC
Rietjens IM
Kok FJ
Aarts JM
Kampman E
Pokaż więcej
Źródło:
Nutrition and cancer [Nutr Cancer] 2008; Vol. 60 (2), pp. 204-15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fruit*
Genetic Variation*
Polymorphism, Genetic*
Vegetables*
Colorectal Neoplasms/*enzymology
NAD(P)H Dehydrogenase (Quinone)/*genetics
Adult ; Aged ; Colorectal Neoplasms/epidemiology ; Colorectal Neoplasms/etiology ; Colorectal Neoplasms/genetics ; Enzyme Activation ; Female ; Genotype ; Humans ; Life Style ; Lymphocytes/enzymology ; Male ; Middle Aged ; NAD(P)H Dehydrogenase (Quinone)/metabolism ; Phenotype ; RNA, Messenger/metabolism ; Risk Assessment ; Risk Factors ; Sigmoidoscopy
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies